Teoxane
GENEVE, CH· latest recorded location
TEOXANE is named on 16 US grants and 22 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 16
- Published applications
- 22
- Inventors
- 13
- Granted in 2026 so far
- 0
- Most recent grant
- 9 Aug 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 2 |
| 2016 | 4 | 2 |
| 2017 | 1 | 1 |
| 2018 | 3 | 5 |
| 2019 | 4 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 2 | 1 |
| 2023 | 0 | 3 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 38 documents
- A61KMedicines and medical preparations37
- A61QSpecific use of cosmetics or similar toiletry preparations37
- A61LMethods or apparatus for sterilising materials or objects in general23
- A61PTherapeutic uses of medicines23
- C08BPolysaccharides15
- C08JWorking-up11
- C08LCompositions of macromolecular compounds9
- C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds2
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
- C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients1
Recent patents
- Composition comprising hyaluronic acid and mepivacaine9 Aug 2022US 11,406,738 B2
- Topical composition comprising crosslinked hyaluronic acid and a polyacrylate compound26 Apr 2022US 11,311,472 B2
- Composition comprising hyaluronic acid and mepivacaine29 Sep 2020US 10,786,601 B2
- Composition comprising hyaluronic acid and mepivacaine17 Sep 2019US 10,413,637 B2
- Composition comprising hyaluronic acid and mepivacaine18 Jun 2019US 10,322,212 B2
- Method for Preparing a Sterile Hydrogel Comprising a Cross-Linked or Non-Crosslinked Polysaccharide or a Mixture Thereof20 Aug 2026US 2026/0241069 A1
- Method for Preparing a Sterile Hydrogel Comprising a Cross-Linked or Non-Crosslinked Polysaccharide or a Mixture Thereof4 Jun 2026US 2026/0151540 A1
- Hydrogels for soft tissue filling14 Aug 2025US 2025/0255798 A1
- Method of selecting compositions comprising crosslinked hyaluronic acid and a low proportion of soluble hyaluronic acid of low molecular weight30 Nov 2023US 2023/0383016 A1
- Hydrogel comprising a cross-linked and silylated polysaccharide and process for obtaining same19 Oct 2023US 2023/0330305 A1
Most cited
By later US patents
- Packaging33US D712,247 S12014 · Design
- Composition comprising hyaluronic acid and mepivacaine5US 9,421,198 B22016
- Composition comprising hyaluronic acid and mepivacaine4US 9,498,562 B12016
- Composition comprising hyaluronic acid and mepivacaine4US 9,789,226 B22017
- Composition comprising hyaluronic acid and mepivacaine2US 9,925,309 B22018